Walleye Capital LLC bought a new position in shares of Cutera, Inc. (NASDAQ:CUTR – Get Rating) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 19,116 shares of the medical device company's stock, valued at approximately $1,319,000. Walleye Capital LLC owned about 0.11% of Cutera at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in CUTR. Captrust Financial Advisors increased its holdings in Cutera by 592.2% in the first quarter. Captrust Financial Advisors now owns 533 shares of the medical device company's stock valued at $37,000 after buying an additional 456 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank purchased a new position in Cutera in the first quarter valued at $95,000. Everence Capital Management Inc. purchased a new position in Cutera in the first quarter valued at $218,000. Teacher Retirement System of Texas purchased a new position in Cutera in the first quarter valued at $220,000. Finally, SG Americas Securities LLC purchased a new position in Cutera in the first quarter valued at $233,000.

Cutera Stock Performance

CUTR opened at $48.89 on Friday. The firm has a market capitalization of $957.27 million, a PE ratio of -13.32 and a beta of 1.84. Cutera, Inc. has a twelve month low of $31.62 and a twelve month high of $74.38. The firm's 50-day moving average price is $46.67 and its 200 day moving average price is $49.29. The company has a current ratio of 4.36, a quick ratio of 3.83 and a debt-to-equity ratio of 12.56.

Wall Street Analyst Weigh In

A number of research firms have weighed in on CUTR. Piper Sandler cut their price objective on shares of Cutera from $65.00 to $55.00 and set an "overweight" rating for the company in a report on Friday, August 5th. StockNews.com upgraded shares of Cutera to a "sell" rating in a research report on Friday, September 2nd. Maxim Group reiterated a "buy" rating and issued a $80.00 target price on shares of Cutera in a research report on Friday, August 5th. Finally, TheStreet lowered shares of Cutera from a "c-" rating to a "d+" rating in a research report on Thursday, July 7th.

Cutera Profile

(Get Rating)

Cutera, Inc, a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide. The company offers Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; excel V+, a vascular and benign pigmented lesion treatment platform; truSculpt iD, for the non-surgical body sculpting market; and Secret RF, a fractional RF microneedling system for tissue coagulation and hemostasis.

Featured Articles

• Get a free copy of the StockNews.com research report on Cutera (CUTR)
• 3 Banks Worth Considering For Q4
• Stock Market: 3 Islands Of Strength In A Sea Of Red
• Is There a Cure for What is Ailing Teladoc Stock?
• MarketBeat: Week in Review 9/12 – 9/16
• No One Told These 3 Stocks It's a Down Week

Want to see what other hedge funds are holding CUTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cutera, Inc. (NASDAQ:CUTR – Get Rating).

Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.